Format
Items per page
Sort by

Send to:

Choose Destination

Search results

Items: 1 to 20 of 225

1.

'As required' medication regimens for seriously mentally ill people in hospital.

Douglas-Hall P, Whicher EV.

Cochrane Database Syst Rev. 2015 Dec 21;(12):CD003441. doi: 10.1002/14651858.CD003441.pub3. Review.

PMID:
26689942
2.

Comparative Effectiveness of Clozapine and Standard Antipsychotic Treatment in Adults With Schizophrenia.

Stroup TS, Gerhard T, Crystal S, Huang C, Olfson M.

Am J Psychiatry. 2016 Feb 1;173(2):166-73. doi: 10.1176/appi.ajp.2015.15030332. Epub 2015 Nov 6.

PMID:
26541815
3.

Delays before Diagnosis and Initiation of Treatment in Patients Presenting to Mental Health Services with Bipolar Disorder.

Patel R, Shetty H, Jackson R, Broadbent M, Stewart R, Boydell J, McGuire P, Taylor M.

PLoS One. 2015 May 20;10(5):e0126530. doi: 10.1371/journal.pone.0126530. eCollection 2015.

4.

Clozapine revisited: Impact of clozapine vs olanzapine on health care use by schizophrenia patients on Medicaid.

Thomas KL, Jiang Y, McCombs JS.

Ann Clin Psychiatry. 2015 May;27(2):90-9.

PMID:
25696785
5.

Antipsychotic polypharmacy among elderly patients with schizophrenia and dementia during hospitalization at a Taiwanese psychiatric hospital.

Wu YH, Lai CY, Chang YS.

Psychogeriatrics. 2015 Mar;15(1):7-13. doi: 10.1111/psyg.12067. Epub 2014 Dec 17.

PMID:
25515355
6.

[Theory and practice of pharmacological treatment of acute schizophrenia: a retrospective study].

Potanin SS, Burminskiĭ DS, Morozova MA.

Zh Nevrol Psikhiatr Im S S Korsakova. 2014;114(5):17-21. Russian.

PMID:
24988953
7.

The prevalence of antipsychotic polypharmacy in schizophrenic patients discharged from psychiatric units in Poland.

Jaracz J, Tetera-Rudnicka E, Kujath D, Raczyńska A, Stoszek S, Czernaś W, Wierzbiński P, Moniakowski A, Jaracz K, Rybakowski J.

Pharmacol Rep. 2014 Aug;66(4):613-7. doi: 10.1016/j.pharep.2014.02.024. Epub 2014 Apr 25.

PMID:
24948062
8.

Psychiatrist and patient responses to suspected medication nonadherence in schizophrenia spectrum disorders.

Hamann J, Lipp ML, Christ-Zapp S, Spellmann I, Kissling W.

Psychiatr Serv. 2014 Jul;65(7):881-7. doi: 10.1176/appi.ps.201300322.

PMID:
24686753
9.

Involuntary treatment of psychiatric inpatients certified under the Saskatchewan Mental Health Services Act in a secure forensic psychiatric treatment center.

Adelugba O, Mela M, Haq I.

Med Sci Law. 2015 Apr;55(2):113-20. doi: 10.1177/0025802414527048. Epub 2014 Mar 18.

PMID:
24644230
10.

Infection and inflammation leading to clozapine toxicity and intensive care: a case series.

Leung JG, Nelson S, Takala CR, Gören JL.

Ann Pharmacother. 2014 Jun;48(6):801-5. doi: 10.1177/1060028014526701. Epub 2014 Mar 11.

PMID:
24619948
11.

Insight and attitudes towards medication among inpatients with chronic schizophrenia in the US and China.

Mohamed S, Rosenheck R, He H, Yuping N.

Soc Psychiatry Psychiatr Epidemiol. 2014 Jul;49(7):1063-70. doi: 10.1007/s00127-014-0824-1. Epub 2014 Feb 19.

PMID:
24549835
12.

Changes in delusions in the early phase of antipsychotic treatment - an experience sampling study.

So SH, Peters ER, Swendsen J, Garety PA, Kapur S.

Psychiatry Res. 2014 Mar 30;215(3):568-73. doi: 10.1016/j.psychres.2013.12.033. Epub 2013 Dec 24.

PMID:
24412352
13.

Is disorganized schizophrenia a predictor of treatment resistance? Evidence from an observational study.

Ortiz BB, Araújo Filho GM, Araripe Neto AG, Medeiros D, Bressan RA.

Rev Bras Psiquiatr. 2013 Oct-Dec;35(4):432-4. doi: 10.1590/1516-4446-2013-1190. Epub 2013 Dec 23.

14.

A randomized placebo-controlled trial of an omega-3 fatty acid and vitamins E+C in schizophrenia.

Bentsen H, Osnes K, Refsum H, Solberg DK, Bøhmer T.

Transl Psychiatry. 2013 Dec 17;3:e335. doi: 10.1038/tp.2013.110.

15.

[Clinical experience with clozapine in 55 cases of treatment-resistant schizophrenia].

Enomoto T, Ito T, Sekine K, Yasui R, Ashizawa Y, Uju Y, Hayakawa T, Tsukada K.

Seishin Shinkeigaku Zasshi. 2013;115(9):953-66. Japanese.

PMID:
24228473
16.

The nature and evolution of insight in schizophrenia: a multi-informant longitudinal study of first-episode versus chronic patients.

Koren D, Viksman P, Giuliano AJ, Seidman LJ.

Schizophr Res. 2013 Dec;151(1-3):245-51. doi: 10.1016/j.schres.2013.10.013. Epub 2013 Nov 1.

PMID:
24189291
17.

Hallucinations in acutely admitted patients with psychosis, and effectiveness of risperidone, olanzapine, quetiapine, and ziprasidone: a pragmatic, randomized study.

Johnsen E, Sinkeviciute I, Løberg EM, Kroken RA, Hugdahl K, Jørgensen HA.

BMC Psychiatry. 2013 Sep 30;13:241. doi: 10.1186/1471-244X-13-241.

18.

Psychiatric claims to the Danish Patient Insurance Association have low recognition percentages.

Steinø P, Jørgensen CB, Christoffersen JK.

Dan Med J. 2013 Aug;60(8):A4621.

PMID:
23905560
19.

Demonstrating the effectiveness of less restrictive care pathways for the management of patients treated with clozapine.

Filia S, Lee S, Sinclair K, Wheelhouse A, Wilkins S, de Castella A, Kulkarni J.

Australas Psychiatry. 2013 Oct;21(5):449-55. doi: 10.1177/1039856213498427. Epub 2013 Jul 29.

PMID:
23897737
20.

Hospitalisation rates in patients switched from oral anti-psychotics to aripiprazole once-monthly for the management of schizophrenia.

Kane JM, Sanchez R, Zhao J, Duca AR, Johnson BR, McQuade RD, Eramo A, Baker RA, Peters-Strickland T.

J Med Econ. 2013 Jul;16(7):917-25. doi: 10.3111/13696998.2013.804411. Epub 2013 May 28.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk